What Bioquell does

Bioquell designs, manufactures, and services bio-decontamination systems based on proprietary 35% Hydrogen Peroxide Vapor (HPV) technology. The HPV process is a four-stage cycle (Preparation, Vaporization, Dwell, Aeration) that achieves a validated 6-log sporicidal kill on exposed surfaces while leaving no residue, allowing equipment to be immediately operational without post-cycle wipe-down. Bioquell's product range includes mobile and fixed HPV generators (ProteQ, L-4, IG-2, SeQure), the customizable Qube polypropylene pharmaceutical isolator with a 16-week install/validation cycle, and the Integrated Building Decontamination System (IBDS) for centralized facility-level decontamination via HVAC distribution and BMS integration. The portfolio is EPA-registered, BPR-compliant, GMP-aligned, and supports 21 CFR Part 11 audit trails, with consumables (RFID-tagged 35% hydrogen peroxide sterilant and in-house Geobacillus stearothermophilus biological indicators) sold alongside the hardware estate.

Bioquell serves pharmaceutical manufacturing and compounding, biotechnology and drug development, gene and cell therapy, hospitals and patient care, and research laboratories. End users include pharma manufacturers operating GMP/GLP cleanrooms, advanced therapy manufacturers handling cell and gene material, and NHS hospitals using the service for infection prevention and outbreak response. The company also publishes over 50 peer-reviewed references and offers a free contamination control webinar series targeting cell and gene therapy manufacturers.

The business operates three revenue streams: (1) equipment and systems sales (ProteQ, Qube, SeQure, L-4, IG-2, IBDS); (2) recurring consumables (hydrogen peroxide sterilant, biological and chemical indicators); and (3) professional services including the Rapid Bio-Decontamination Service (RBDS) for on-site managed decontamination and validation services (IQ/OQ, customized cycle development). Go-to-market is enterprise field sales via wholly-owned subsidiaries in seven countries (UK, USA, France, Germany, Ireland, China, Singapore) under the Ecolab Life Sciences brand, complemented by the QuAD Quality Assurance Data Portal for digital cycle and compliance documentation. Bioquell is a wholly-owned subsidiary of Ecolab Inc., and pricing is not publicly disclosed — customers are directed to regional sales teams for quotes.

Name

Bioquell

Legal name

Bioquell Group (Bioquell PLC)

Website

https://bioquell.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

251–500 employees

Short description

Bioquell designs, manufactures, and services Hydrogen Peroxide Vapor (HPV) bio-decontamination systems, isolators, and on-site decontamination services for pharmaceutical manufacturing, biotechnology, gene and cell therapy, hospital infection control, and life sciences research, operating as a wholly-owned subsidiary of Ecolab Inc.

Ownership category

akta.pro rank

Product category

Bio-decontamination Equipment

NAICS

Irradiation Apparatus Manufacturing (334517)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Bioprocess Safety, Biosafety & Contamination Control Solutions (single-use integrity, environmental monitoring) (HLAAAJAO)

akta.pro secondary industries

Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI), Infectious Disease/Pathogen Decontamination (HSAEAHAF), Biohazard Spill Response & Decontamination Services (BPALAGAH)

Keywords

• Hydrogen peroxide vapor
• Bio-decontamination systems
• Pharmaceutical contamination control
• Cleanroom decontamination services
• Aseptic manufacturing solutions

Headquarters

HQ city

Andover

HQ country

United Kingdom

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Equipment and Systems Sales: Sale of Bioquell HPV decontamination systems including ProteQ, Qube, SeQure, L-4, IG-2, and Integrated Building Decontamination Systems. Systems are sold directly to pharmaceutical, life sciences, and healthcare facilities.
2. Rapid Bio-Decontamination Service (RBDS): On-site decontamination services provided by skilled Bioquell personnel for facilities that do not have resources, time, or equipment. Service includes full reporting with biological and chemical indicator results.
3. Consumables: Hydrogen peroxide sterilant (35% concentration with RFID tagging), biological indicators, and chemical indicators for use with Bioquell systems. Consumables are provided in traceable bottles with certificates of analysis.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Bioquell designs, manufactures and services bio-decontamination systems based on its proprietary 35% Hydrogen Peroxide Vapor (HPV) technology, including the ProteQ mobile unit, Qube pharmaceutical isolator, SeQure, L-4, IG-2, and Integrated Building Decontamination Systems. The company also delivers the on-site Rapid Bio-Decontamination Service (RBDS) using HPV and supplies consumables (biological indicators, chemical indicators and hydrogen peroxide sterilant) plus validation services for pharmaceutical, life sciences and healthcare facilities.

Product overview

Bioquell, an Ecolab company, provides a comprehensive hydrogen peroxide vapor (HPV) bio-decontamination portfolio consisting of proprietary 35% Hydrogen Peroxide Vapor technology as the core platform, supported by multiple product systems (ProteQ mobile unit, Qube isolator, SeQure fixed system, L-4 and IG-2 generators, and Integrated Building Decontamination System) and the Rapid Bio-Decontamination Service (RBDS) for managed on-site decontamination. The portfolio includes complementary consumables (biological/chemical indicators, hydrogen peroxide sterilant), validation services, and the QuAD data management portal. Products serve pharmaceutical manufacturing, life sciences R&D, healthcare, and biotech applications with EPA registration and BPR compliance.

Differentiator

Problem solved

Functional benefit

Brands

• Bioquell Qube: Pharmaceutical isolator integrated with Hydrogen Peroxide Vapor technology for sterility testing, gene & cell therapy, small batch production, compounding, and cytotoxic preparation
• Bioquell ProteQ
• Bioquell SeQure
• Bioquell L-4
• Bioquell IG-2
• Bioquell RBDS
• Bioquell IBDS
• Bioquell HPV-AQ

Products and services

• Bioquell ProteQ Mobile, scalable Hydrogen Peroxide Vapor generator with wireless communication technology. All components including aeration are hosted within the frame for simple setup. Designed for biopharmaceutical manufacturing areas, production labs, room and zone decontamination, bio-safety labs, cleanrooms, and GMP/GLP laboratories.
• Bioquell Qube Pharmaceutical Isolator Customizable pharmaceutical isolator integrated with Hydrogen Peroxide Vapor technology. Constructed from polypropylene (not stainless steel) for quick installation and validation within 16 weeks. Used for sterility testing, gene and cell therapy, small batch production, compounding, and cytotoxic preparation.
• Bioquell SeQure Fixed, wall-mounted bio-decontamination system for pass-throughs, material airlocks, lab and room decontamination, and spaces smaller than 150 cubic meters. Designed for viral and bacterial vector work, biosecurity and small research areas.
• Bioquell L-4 Versatile, multipurpose Hydrogen Peroxide Vapor generator for enclosed systems and equipment up to larger rooms and spaces (up to 250 cubic meters with optional distribution head). Compatible with isolators, RABS, freeze dryers, bio-safety cabinets, cage and rack washers, incubators, and filter bank enclosures.
• Bioquell IG-2 System integration solution for RABS, filling lines, cage and rack washers, robotic enclosures, material airlocks, and small-volume rooms. Offers remote-control screen and 21 CFR Part 11 audit trail compliance for electronic records.
• Bioquell Integrated Building Decontamination System (IBDS) Fully integrated, centralized bio-decontamination solution designed for frequent or routine decontamination of the same area. Equipment is located in unclassified area with vapor distributed through building HVAC or dedicated pipe network, controlled via Building Management System (BMS) integration. Validated 6-log sporicidal kill for GMP biopharmaceutical manufacturing, filling suites, biomedical facilities and biosafety laboratories.
• Rapid Bio-Decontamination Service (RBDS) On-site managed decontamination service delivered by trained Bioquell personnel using Hydrogen Peroxide Vapor. Available for spaces from smallest enclosures to large buildings, including BSL-2/3/4 labs, post-construction commissioning, pharmaceutical production and emergency containment. Includes full reporting with biological and chemical indicators confirming 6-log sporicidal kill, cycle parameters, and environmental conditions.
• Bioquell Biological Indicators In-house manufactured biological indicators using Geobacillus stearothermophilus endospores with over one million spores per carrier disc. Available in boxes of 20 or 100 with re-sealable wallets of 20 each for cycle validation in Bioquell decontamination systems.
• Bioquell Chemical Indicators In-house manufactured chemical indicators with reactive dye that changes color when exposed to Hydrogen Peroxide Vapor, providing real-time cycle success indication. Available in boxes of 20 or 100 for use with Bioquell decontamination systems.
• Bioquell Hydrogen Peroxide Sterilant (HPV-AQ) 35% hydrogen peroxide sterilant solution (EPA Registration Number: 72372-1-86703) supplied in RFID-tagged bottles for traceability, volume tracking, GMP documentation and cycle reproducibility with Bioquell decontamination systems.
• Bioquell Validation Services Professional validation, maintenance and customer service support including Installation and Operational Qualification (IQ/OQ), customized cycle development, and regulatory compliance verification for Bioquell decontamination systems installed at customer sites.

Quantifiable outcome

• 99.9999% pathogen reduction (6-log kill) on all exposed surfaces
• +2 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature9 records

Partnerships

One partnership is on record.

• EcolabflagshipStrategic or Co-development PartnerBioquell is a subsidiary of Ecolab Inc., operating under the Ecolab Life Sciences division. The partnership provides Bioquell with Ecolab's global distribution network, resources, and integration into a broader contamination control portfolio. Bioquell technology is marketed as part of Ecolab Life Sciences Complete Solutions.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Getinge: Getinge offers pharmaceutical isolators, sterilization equipment, and infection control solutions for life sciences and healthcare, overlapping with Bioquell's Qube isolator and ProteQ decontamination systems serving GMP-regulated manufacturers and hospitals.
• Halma plc: Halma is a UK-listed group of safety and environmental technology companies with several subsidiaries in life sciences decontamination, gas detection, and process analytics; relevant as a comparable diversified industrial safety conglomerate with bio-decontamination adjacencies.
• Belimed (Metall Zug): Belimed provides infection control and sterilization equipment for hospitals and life sciences, with overlapping reach into pharma decontamination and CSSD markets where Bioquell competes.

Direct peers

• Steris plc: Steris is the most direct competitor, offering Vaporized Hydrogen Peroxide (VHP) bio-decontamination systems alongside a much broader sterilization, infection prevention, and lab equipment portfolio serving the same pharmaceutical, biotech, and healthcare customers as Bioquell.
• Fedegari Group: Fedegari manufactures autoclaves, washer-disinfectors, and bio-decontamination systems (including vaporized H2O2 platforms) for pharmaceutical and hospital customers, positioning it as a direct comparable for Bioquell's equipment line.
• SKAN AG: SKAN is a leading pharmaceutical isolator specialist with ~30% market share, directly comparable to Bioquell Qube and competing for sterility testing, gene/cell therapy, and aseptic manufacturing installations in regulated GMP environments.
• Tomí Environmental Solutions: Tomi offers SteraMist, an ionized Hydrogen Peroxide vapor decontamination technology, directly competing with Bioquell HPV across pharmaceutical, healthcare, and biosafety applications with a focus on surface and room decontamination.

Emerging players

• ClorDiSys Solutions: ClorDiSys specializes in chlorine dioxide gas decontamination for cleanrooms, laboratories, and BSL-3/4 facilities, providing an alternative bio-decontamination chemistry to Bioquell's hydrogen peroxide vapor in comparable life sciences and healthcare applications.
• Shinva Medical Instrument: Shinva is a Chinese sterilization and infection control equipment manufacturer with growing international presence, competing in the same low-temperature bio-decontamination and sterilizer categories relevant to Bioquell's APAC strategy.
• Tuttnauer: Tuttnauer manufactures autoclaves, plasma sterilizers, and laboratory decontamination equipment for pharma, research, and healthcare — a partial-overlap competitor in sterilization and bio-decontamination categories where Bioquell competes.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/bioquell
• Facebookfacebook.com/bioquell

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioquell